INDRAMEDCO.NS Stock Analysis
IN
Neutral
Based on Eyestock quantitative analysis, INDRAMEDCO.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Market cap $B
0.051
Dividend yield
1.58 %
Shares outstanding
91.673 B
Indraprastha Medical Corp. Ltd. engages in the healthcare business. The company is headquartered in New Delhi, Delhi and currently employs 2,947 full-time employees. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The firm provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.